Literature DB >> 19538241

The relationship between depression and diabetes mellitus: findings from the Hertfordshire Cohort Study.

R I G Holt1, D I W Phillips, K A Jameson, C Cooper, E M Dennison, R C Peveler.   

Abstract

AIMS: To assess the relationship between depression scores and diabetes, glucose and insulin in a cross-sectional population-based study.
METHODS: One thousand, five hundred and seventy-nine men and 1418 women from the Hertfordshire Cohort Study were assessed for diabetes. Plasma glucose and insulin concentrations were measured at 0, 30 and 120 min during a standard 75-g oral glucose tolerance test. Depressive and anxiety symptoms were measured using the Hospital Anxiety and Depression Scale (HADS).
RESULTS: Overall, 431 (14.6%) were diagnosed with diabetes [232 men (14.9%) and 199 women (14.3%)]. One hundred and eight (47%) men and 74 (37%) women had known diabetes. The remainder were previously undiagnosed. Fifty-nine (3.7%) men and 65 (4.6%) women had possible depression (HAD-D scores 8-10) and 17 (1.1%) men and 20 (1.4%) women had probable depression (HAD-D scores > or = 11). Probable depression was associated with an adjusted odds ratio for diabetes of 3.89 [95% confidence interval (CI) 1.28-11.88] in men and 1.51 (95% CI 0.47-4.84) in women. In men without previously diagnosed diabetes, fasting insulin (P = 0.035), 2-h glucose concentrations (P = 0.028) and insulin resistance (P = 0.032) were significantly associated with HAD-D scores. With the exception of 2-h glucose concentrations (P = 0.034), the associations were not significant in women.
CONCLUSIONS: These data support the hypothesis that depression may increase the risk for diabetes. The relationship between depression score and metabolic variables extends across the whole population and is not confined to those with either diagnosed depression or diabetes. This relationship should lead clinicians to consider screening for diabetes in those with depression and vice versa.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538241     DOI: 10.1111/j.1464-5491.2009.02742.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  27 in total

1.  Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.

Authors:  M Elizabeth Sublette; Steven P Ellis; Amy L Geant; J John Mann
Journal:  J Clin Psychiatry       Date:  2011-09-06       Impact factor: 4.384

2.  Is ignorance bliss? Depression, antidepressants, and the diagnosis of prediabetes and type 2 diabetes.

Authors:  Briana Mezuk; Vicki Johnson-Lawrence; Hedwig Lee; Jane A Rafferty; Cleopatra M Abdou; Ekeoma E Uzogara; James S Jackson
Journal:  Health Psychol       Date:  2013-03       Impact factor: 4.267

3.  Depression and Anxiety Screens as Simultaneous Predictors of 10-Year Incidence of Diabetes Mellitus in Older Adults in Primary Care.

Authors:  Tasneem Khambaty; Christopher M Callahan; Anthony J Perkins; Jesse C Stewart
Journal:  J Am Geriatr Soc       Date:  2016-09-19       Impact factor: 5.562

Review 4.  A review of the association between depression and insulin resistance: pitfalls of secondary analyses or a promising new approach to prevention of type 2 diabetes?

Authors:  Naomi Silva; Evan Atlantis; Khalida Ismail
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

5.  Depression, anxiety and glucose metabolism in the general dutch population: the new Hoorn study.

Authors:  Vanessa Bouwman; Marcel C Adriaanse; Esther van 't Riet; Frank J Snoek; Jacqueline M Dekker; Giel Nijpels
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

Review 6.  The comorbidity between depression and diabetes.

Authors:  Bibilola D Oladeji; Oye Gureje
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

7.  Association of depression with pre-diabetes, undiagnosed diabetes, and previously diagnosed diabetes: a meta-analysis.

Authors:  Shengguang Chen; Qian Zhang; Guoxing Dai; Jiawen Hu; Chenting Zhu; Lijie Su; Xianzheng Wu
Journal:  Endocrine       Date:  2016-01-30       Impact factor: 3.633

8.  Differences in the clinical recognition of depression in diabetes patients: the Diabetes Study of Northern California (DISTANCE).

Authors:  Darrell L Hudson; Andrew J Karter; Alicia Fernandez; Melissa Parker; Alyce S Adams; Dean Schillinger; Howard H Moffet; Jufen Zhou; Nancy E Adler
Journal:  Am J Manag Care       Date:  2013-05       Impact factor: 2.229

9.  Factors associated with symptoms of anxiety and depression in five cohorts of community-based older people: the HALCyon (Healthy Ageing across the Life Course) Programme.

Authors:  C R Gale; A Aihie Sayer; C Cooper; E M Dennison; J M Starr; L J Whalley; J E Gallacher; Y Ben-Shlomo; D Kuh; R Hardy; L Craig; I J Deary
Journal:  Psychol Med       Date:  2011-02-24       Impact factor: 7.723

10.  The prevalence of depression in white-European and South-Asian people with impaired glucose regulation and screen-detected type 2 diabetes mellitus.

Authors:  Navneet Aujla; Keith R Abrams; Melanie J Davies; Nick Taub; Timothy C Skinner; Kamlesh Khunti
Journal:  PLoS One       Date:  2009-11-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.